000 01285 a2200373 4500
005 20250513044756.0
264 0 _c19950221
008 199502s 0 0 eng d
022 _a1170-229X
024 7 _a10.2165/00002512-199405040-00001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPhilpot, M
245 0 0 _aPsychotropic drugs, aging and community care.
_h[electronic resource]
260 _bDrugs & aging
_cOct 1994
300 _a235-41 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aAging
_xpathology
650 0 4 _aCommunity Mental Health Services
_xeconomics
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDelusions
_xdrug therapy
650 0 4 _aDementia
_xdrug therapy
650 0 4 _aDepression
_xdrug therapy
650 0 4 _aHomes for the Aged
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aNursing Homes
_xstatistics & numerical data
650 0 4 _aPatient Compliance
650 0 4 _aPsychotropic Drugs
_xadverse effects
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aUnited Kingdom
700 1 _aPuranik, A
773 0 _tDrugs & aging
_gvol. 5
_gno. 4
_gp. 235-41
856 4 0 _uhttps://doi.org/10.2165/00002512-199405040-00001
_zAvailable from publisher's website
999 _c7826738
_d7826738